Hodgkin Lymphoma  >>  epirubicin  >>  Phase 4
Welcome,         Profile    Billing    Logout  

1 Trials

Remove FilterRemove Filter

Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
epirubicin / Generic mfg.
NCT02526823: Clinical Application of Polyethylene Glycol Liposome Doxorubicin (PLD) in Primary Lymphoma

Unknown status
4
360
RoW
R-CHOP/CHOPE or ABVD chemotherapy regimen, R-CDOP/CDOPE or DBVD chemotherapy regimen
Shandong Provincial Hospital
Lymphoma, Non-Hodgkin;Hodgkin Disease
12/19
12/19

Download Options